Kanazawa University · Cancer Research Institute

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Limited SUMOylation inhibitor administration enhances eradication of Burkitt’s lymphoma with CD19 CAR-T therapy Hiroshi Kotani;Shigeki Sato;Seiji Yano;Marco L. Davila;Hiroaki Taniguchi Signal Transduction and Targeted Therapy 2025/10/03 査読有 原著論文 研究論文（学術雑誌）2025 · 論文
• Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage Hiroshi Kotani;Hiroko Oshima;Justin C. Boucher;Tomoyoshi Yamano;Hiroyuki Sakaguchi;Shigeki Sato;Koji Fukuda;Akihiro Nishiyama;Kaname Yamashita;Koushiro Ohtsubo;Shinji Takeuchi;Takumi Nishiuchi;Masanobu Oshima;Marco L. Davila;Seiji Yano Journal of Biomedical Science 2024/07/11 査読有 原著論文 研究論文（学術雑誌）2024 · 論文
• Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers Hiroshi Kotani;Tomoyoshi Yamano;Justin C. Boucher;Shigeki Sato;Hiroyuki Sakaguchi;Koji Fukuda;Akihiro Nishiyama;Kaname Yamashita;Koushiro Ohtsubo;Shinji Takeuchi;Takumi Nishiuchi;Hiroko Oshima;Masanobu Oshima;Marco L. Davila;Seiji Yano Experimental Hematology & Oncology 2024/09/27 査読有 原著論文 研究論文（学術雑誌）2024 · 論文
• 4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells. Roselli E, Boucher JC, Li G, Kotani H, Spitler K, Reid K, Cervantes EV, Bulliard Y, Tu N, Lee SB, Yu B, Locke FL, Davila ML. Journal for ImmunoTherapy of Cancer 2021/10/27 査読有 原著論文 研究論文（学術雑誌）2021 · 論文

• Official profile